Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression.
Clinical trial NCT02785562 · COMPLETED
Trial details
- NCT number
- NCT02785562
- Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-21
- Primary completion
- 2020-04-06
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.